0001209191-22-024064.txt : 20220411
0001209191-22-024064.hdr.sgml : 20220411
20220411200221
ACCESSION NUMBER: 0001209191-22-024064
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220407
FILED AS OF DATE: 20220411
DATE AS OF CHANGE: 20220411
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kihara James
CENTRAL INDEX KEY: 0001816160
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 22820903
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 12830 EL CAMINO REAL, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-04-07
0
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001816160
Kihara James
C/O ACADIA PHARMACEUTICALS, INC.
12830 EL CAMINO REAL, SUITE 400
SAN DIEGO
CA
92130
0
1
0
0
Principal Accounting Officer
Common Stock
2022-04-07
4
M
0
2977
A
3458
D
Common Stock
2022-04-08
4
S
0
1025
27.05
D
2433
D
Restricted Stock Units
2022-04-07
4
M
0
2977
0.00
D
Common Stock
2977
2978
D
Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
50% of the restricted stock units vest on April 7, 2022 and 25% vest on each of April 7, 2023 and April 7, 2024.
/s/ Austin D. Kim, Attorney-in-Fact
2022-04-11